Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 94.10 Delayed Data As of Jun 08 |  +0.49 / +0.52%Today’s Change | 18.47 Today|||52-Week Range 106.69 | +147.70% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Bir Dawn Carter Chief Commercial Officer |  Sale | 3/06/2023 | 40,134 | $89.30 | $3.6M | +6.32% |
Bir Dawn Carter Chief Commercial Officer | Sale | 3/07/2023 | 36,049 | $85.08 | $3.1M | +10.63% |
Meyer Colin Chief Innovation Officer | Sale | 3/02/2023 | 34,794 | $86.49 | $3.0M | +8.40% |
Meyer Colin Chief Innovation Officer | Sale | 3/02/2023 | 22,752 | $85.23 | $1.9M | +8.40% |
Meyer Colin Chief Innovation Officer | Sale | 3/02/2023 | 19,099 | $87.55 | $1.7M | +8.40% |
Khan Samina /quark/ Chief Medical Officer & Senior Vice President | Sale | 3/02/2023 | 18,956 | $85.02 | $1.6M | +8.40% |
Loewen Rodriguez Andrea | Sale | 3/07/2023 | 17,836 | $83.36 | $1.5M | +10.63% |
Bir Dawn Carter Chief Commercial Officer | Sale | 3/06/2023 | 14,820 | $90.26 | $1.3M | +6.32% |
Huff J Warren Chief Executive Officer | Sale | 3/02/2023 | 12,826 | $88.59 | $1.1M | +8.40% |
Soni Manmeet Singh | Sale | 5/15/2023 | 12,440 | $84.32 | $1.0M | +11.23% |
Page of 9